ArticleFrontiers in immunology2026
A 76-week real-world multidimensional analysis of guselkumab in moderate to severe plaque psoriasis: a retrospective cohort study based on Chinese clinical practice standards.
Runlu Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.